Prediction of the Treatment Response in Ovarian Cancer: A Ctdna Approach Publisher Pubmed



Sharbatoghli M^{1, 2} ; Vafaei S^{1, 3} ; Aboulkheyr Es H⁴ ; Asadilari M^{1, 5} ; Totonchi M^{2, 6} ; Madjd Z^{1, 3}
Source: Journal of Ovarian Research Published:2020

Abstract

Abstract: Ovarian cancer is the eighth most commonly occurring cancer in women. Clinically, the limitation of conventional screening and monitoring approaches inhibits high throughput analysis of the tumor molecular markers toward prediction of treatment response. Recently, analysis of liquid biopsies including circulating tumor DNA (ctDNA) open new way toward cancer diagnosis and treatment in a personalized manner in various types of solid tumors. In the case of ovarian carcinoma, growing pre-clinical and clinical studies underscored promising application of ctDNA in diagnosis, prognosis, and prediction of treatment response. In this review, we accumulate and highlight recent molecular findings of ctDNA analysis and its associations with treatment response and patient outcome. Additionally, we discussed the potential application of ctDNA in the personalized treatment of ovarian carcinoma. Graphical abstract: ctDNA-monitoring usage during the ovarian cancer treatments procedures.[Figure not available: see fulltext.]. © 2020, The Author(s).